Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
10.3390/ph16091223 6 AlkahtaniS.Al-Johani NS.AlarifiS.AfzalM
The conversation covers how our understanding of obesity as a chronic, relapsing disease has changed over the past 30 years, what the new clinical versus preclinical obesity framework means for how we diagnose and treat it, how GLP-1 drugs work and why they've succeeded where earlier medications failed, what the STEP and SELECT trials revealed about the disease-modifying potential of semaglutide, and how patients and clinicians should be thinking about who these drugs are really for
People using ineffective patches may delay seeking proven treatments while continuing to lead unhealthy lifestyles
The magic happens during what scientists call Phase II liver detoxification
US$ 27.63
US$ 26.61
:max_bytes(150000):strip_icc()/VWH-GettyImages-2059065209-7ab09bdd0be8409493ace4364fccf792.jpg)
US$ 21.38
